MoneyWorks4Me

Piramal Pharma - Quaterly Results

08 Feb 2023 Evaluate
A minor change in the total revenue was seen in the December 2022 quarter. The total revenue for the quarter stood at Rs. 8132.90 millions against Rs. 7961.30 millions during year ago period.The Net Loss for the quarter ended December 2022 is Rs. -24.20 millions as compared to Net Profit of Rs. 1117.60 millions of corresponding quarter ended December 2021The Operating Profit of the company witnessed a decrease to 811.50 millions from 1945.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202212 202112 % Var
Sales 8132.90 7961.30 2.16 8132.90 7961.30 2.16 8132.90 7961.30 2.16
Other Income 538.80 568.70 -5.26 538.80 568.70 -5.26 538.80 568.70 -5.26
PBIDT 811.50 1945.70 -58.29 811.50 1945.70 -58.29 811.50 1945.70 -58.29
Interest 332.20 152.80 117.41 332.20 152.80 117.41 332.20 152.80 117.41
PBDT 479.30 1792.90 -73.27 479.30 1792.90 -73.27 479.30 1792.90 -73.27
Depreciation 471.90 406.60 16.06 471.90 406.60 16.06 471.90 406.60 16.06
PBT 7.40 1386.30 -99.47 7.40 1386.30 -99.47 7.40 1386.30 -99.47
TAX 31.60 268.70 -88.24 31.60 268.70 -88.24 31.60 268.70 -88.24
Deferred Tax -18.30 -3.60 408.33 -18.30 -3.60 408.33 -18.30 -3.60 408.33
PAT -24.20 1117.60 -102.17 -24.20 1117.60 -102.17 -24.20 1117.60 -102.17
Equity 11933.20 11859.10 0.62 11933.20 11859.10 0.62 11933.20 11859.10 0.62
PBIDTM(%) 9.98 24.44 -59.17 9.98 24.44 -59.17 9.98 24.44 -59.17
Peers
Company Name CMP
Sun Pharma. Inds. 1846.80
Dr. Reddys Labs. 1228.60
Cipla 1390.60
Lupin 2069.80
Zydus Lifesciences 1216.00
View more..